⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.35USD

+0.0000 (+0.00%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ATAI.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 7.35
P/E—
Dvd Ind Yld—
P/B15.46
P/S552.7
Curr EV/T12M EBITDA-17.8
Mkt Cap (USD)2.7B
Curr EV (USD)2.5B
2)

Per Share Data

EPS T12M-0.46
DPS—
Bk Val Per Sh0.48
Rev/Sh0.01
Cash/Sh0.61
Curr Shares Out370.9M
FCF/Sh-0.25
3)

Cash Flow Analysis

P/CF-30.9
Curr P/FCF-30.7
CF/NI0.8
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-1790.3%
Eff Interest Rate5.1%
4)

Growth Potential

Dil EPS 1Y Gr-212.9%
Cap 1Y Gr161.2%
BPS 1Y Gr34.9%
R&D To Sales18.2%
Retention Rate100.0%
Rev 1Y Gr1227.6%
FCF 1Y Gr-25.6%
Assets 1Y Gr83.7%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-2447.0%
Pretax Margin-2356.6%
Net Margin-2361.4%
ROA-51.5%
ROE-68.9%
ROC—
Asset Turnover0.02
6)

Structure

Current Ratio8.58
Quick Ratio8.29
Debt/Assets8.7%
Debt/Com Eq13.0%
Net Debt/EBITDA1.21
Tot Debt/Capital11.5%
Gross Margin0.0%
EBIT/Int Exp-103.7

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.